Skip to main content
Erschienen in: Endocrine 3/2019

02.03.2019 | Original Article

Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease

verfasst von: Chen-Tian Shen, Guo-Qiang Zhang, Zhong-Ling Qiu, Hong-Jun Song, Zhen-Kui Sun, Quan-Yong Luo

Erschienen in: Endocrine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purposess

The purpose of this study was using next-generation sequencing technique to explore the potential association between germline variants of 14 targeted genes and papillary thyroid carcinoma (PTC) predisposition as well as disease progression.

Methods

In all, 516 subjects were enrolled in this study including 416 PTC patients and 100 healthy controls. PTC patients were divided into distant metastasis group and non-distant metastasis group. Patients in distant metastasis group were further divided into radioiodine-refractory PTC (RR-PTC) and non-RR-PTC depending on their response to radioiodine therapy. Genomic DNA was extracted from peripheral blood sample and MiSeq Benchtop Sequencer was used for sequencing.

Results

We found rs11246050 in NLRP6 (dominant model, OR/95% CI: 2.028/1.091–3.769, p = 0.025), rs2286742 and rs3740530 in HABP2 (recessive model, OR/95% CI: 9.644/1.307–71.16, p = 0.026 and 3.989/1.413–11.26, p = 0.009), rs2736098 in TERT (recessive model, OR/95% CI: 2.322/1.028–5.242. p = 0.042) and rs62054619 in GAS8-AS1 (recessive model, OR/95% CI: 2.219/1.067–4.617, p = 0.033) were associated with the risk of PTC. rs1137282 in KRAS (dominant model, OR/95% CI: 0.5430/0.3192–0.9236, p = 0.024), rs1347591 and rs4461062 in NUP93 (dominant model, OR/95% CI: 0.6121/0.4128–0.9076, p = 0.015 and 0.6156/0.4157–0.9117, p = 0.015) were associated with low risk of distant metastatic disease in PTC patients. rs33954691 in TERT was associated with the risk of RR-PTC under dominant model (OR/95% CI: 3.161/1.596–6.262).

Conclusions

Germline variants of related genes could be associated with the susceptibility of PTC as well as disease progression (distant metastasis and radioiodine-refractory status). However, these results must be further verified and the potential biological functions of these germline variants in the pathogenesis of PTC remain to be determined in future studies.
Literatur
4.
Zurück zum Zitat J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, A. Sigurdsson, J.T. Bergthorsson, H. He, T. Blondal, F. Geller, M. Jakobsdottir, D.N. Magnusdottir, S. Matthiasdottir, S.N. Stacey, O.B. Skarphedinsson, H. Helgadottir, W. Li, R. Nagy, E. Aguillo, E. Faure, E. Prats, B. Saez, M. Martinez, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, K. Kristjansson, M.L. Frigge, H. Kristvinsson, J.R. Gulcher, T. Jonsson, T. Rafnar, H. Hjartarsson, J.I. Mayordomo, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, A. Kong, K. Stefansson, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41(4), 460–464 (2009). https://doi.org/10.1038/ng.339 CrossRefPubMedPubMedCentral J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, A. Sigurdsson, J.T. Bergthorsson, H. He, T. Blondal, F. Geller, M. Jakobsdottir, D.N. Magnusdottir, S. Matthiasdottir, S.N. Stacey, O.B. Skarphedinsson, H. Helgadottir, W. Li, R. Nagy, E. Aguillo, E. Faure, E. Prats, B. Saez, M. Martinez, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, K. Kristjansson, M.L. Frigge, H. Kristvinsson, J.R. Gulcher, T. Jonsson, T. Rafnar, H. Hjartarsson, J.I. Mayordomo, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, A. Kong, K. Stefansson, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41(4), 460–464 (2009). https://​doi.​org/​10.​1038/​ng.​339 CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat M. Takahashi, V.A. Saenko, T.I. Rogounovitch, T. Kawaguchi, V.M. Drozd, H. Takigawa-Imamura, N.M. Akulevich, C. Ratanajaraya, N. Mitsutake, N. Takamura, L.I. Danilova, M.L. Lushchik, Y.E. Demidchik, S. Heath, R. Yamada, M. Lathrop, F. Matsuda, S. Yamashita, The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum. Mol. Genet. 19(12), 2516–2523 (2010). https://doi.org/10.1093/hmg/ddq123 CrossRefPubMed M. Takahashi, V.A. Saenko, T.I. Rogounovitch, T. Kawaguchi, V.M. Drozd, H. Takigawa-Imamura, N.M. Akulevich, C. Ratanajaraya, N. Mitsutake, N. Takamura, L.I. Danilova, M.L. Lushchik, Y.E. Demidchik, S. Heath, R. Yamada, M. Lathrop, F. Matsuda, S. Yamashita, The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum. Mol. Genet. 19(12), 2516–2523 (2010). https://​doi.​org/​10.​1093/​hmg/​ddq123 CrossRefPubMed
6.
Zurück zum Zitat J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, G. Masson, H. He, A. Jonasdottir, A. Sigurdsson, S.N. Stacey, H. Johannsdottir, H.T. Helgadottir, W. Li, R. Nagy, M.D. Ringel, R.T. Kloos, M.C. de Visser, T.S. Plantinga, M. den Heijer, E. Aguillo, A. Panadero, E. Prats, A. Garcia-Castano, A. De Juan, F. Rivera, G.B. Walters, H. Bjarnason, L. Tryggvadottir, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, I. Olafsson, K. Kristjansson, H. Kristvinsson, O.T. Magnusson, G. Thorleifsson, J.R. Gulcher, A. Kong, L.A. Kiemeney, T. Jonsson, H. Hjartarson, J.I. Mayordomo, R.T. Netea-Maier, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, T. Rafnar, K. Stefansson, Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44(3), 319–322 (2012). https://doi.org/10.1038/ng.1046 CrossRefPubMedPubMedCentral J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, G. Masson, H. He, A. Jonasdottir, A. Sigurdsson, S.N. Stacey, H. Johannsdottir, H.T. Helgadottir, W. Li, R. Nagy, M.D. Ringel, R.T. Kloos, M.C. de Visser, T.S. Plantinga, M. den Heijer, E. Aguillo, A. Panadero, E. Prats, A. Garcia-Castano, A. De Juan, F. Rivera, G.B. Walters, H. Bjarnason, L. Tryggvadottir, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, I. Olafsson, K. Kristjansson, H. Kristvinsson, O.T. Magnusson, G. Thorleifsson, J.R. Gulcher, A. Kong, L.A. Kiemeney, T. Jonsson, H. Hjartarson, J.I. Mayordomo, R.T. Netea-Maier, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, T. Rafnar, K. Stefansson, Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44(3), 319–322 (2012). https://​doi.​org/​10.​1038/​ng.​1046 CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat H.Y. Son, Y. Hwangbo, S.K. Yoo, S.W. Im, S.D. Yang, S.J. Kwak, M.S. Park, S.H. Kwak, S.W. Cho, J.S. Ryu, J. Kim, Y.S. Jung, T.H. Kim, S.J. Kim, K.E. Lee, D.J. Park, N.H. Cho, J. Sung, J.S. Seo, E.K. Lee, Y.J. Park, J.I. Kim, Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer. Nat. Commun. 8, 15966 (2017). https://doi.org/10.1038/ncomms15966 CrossRefPubMedPubMedCentral H.Y. Son, Y. Hwangbo, S.K. Yoo, S.W. Im, S.D. Yang, S.J. Kwak, M.S. Park, S.H. Kwak, S.W. Cho, J.S. Ryu, J. Kim, Y.S. Jung, T.H. Kim, S.J. Kim, K.E. Lee, D.J. Park, N.H. Cho, J. Sung, J.S. Seo, E.K. Lee, Y.J. Park, J.I. Kim, Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer. Nat. Commun. 8, 15966 (2017). https://​doi.​org/​10.​1038/​ncomms15966 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Y.L. Wang, S.H. Feng, S.C. Guo, W.J. Wei, D.S. Li, Y. Wang, X. Wang, Z.Y. Wang, Y.Y. Ma, L. Jin, Q.H. Ji, J.C. Wang, Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J. Med. Genet. 50(10), 689–695 (2013). https://doi.org/10.1136/jmedgenet-2013-101687 CrossRefPubMed Y.L. Wang, S.H. Feng, S.C. Guo, W.J. Wei, D.S. Li, Y. Wang, X. Wang, Z.Y. Wang, Y.Y. Ma, L. Jin, Q.H. Ji, J.C. Wang, Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J. Med. Genet. 50(10), 689–695 (2013). https://​doi.​org/​10.​1136/​jmedgenet-2013-101687 CrossRefPubMed
9.
Zurück zum Zitat M. Matsuse, M. Takahashi, N. Mitsutake, E. Nishihara, M. Hirokawa, T. Kawaguchi, T. Rogounovitch, V. Saenko, A. Bychkov, K. Suzuki, K. Matsuo, K. Tajima, A. Miyauchi, R. Yamada, F. Matsuda, S. Yamashita, The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J. Med. Genet. 48(9), 645–648 (2011). https://doi.org/10.1136/jmedgenet-2011-100063 CrossRefPubMed M. Matsuse, M. Takahashi, N. Mitsutake, E. Nishihara, M. Hirokawa, T. Kawaguchi, T. Rogounovitch, V. Saenko, A. Bychkov, K. Suzuki, K. Matsuo, K. Tajima, A. Miyauchi, R. Yamada, F. Matsuda, S. Yamashita, The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J. Med. Genet. 48(9), 645–648 (2011). https://​doi.​org/​10.​1136/​jmedgenet-2011-100063 CrossRefPubMed
10.
11.
Zurück zum Zitat A.M. Jones, K.M. Howarth, L. Martin, M. Gorman, R. Mihai, L. Moss, A. Auton, C. Lemon, H. Mehanna, H. Mohan, S.E. Clarke, J. Wadsley, E. Macias, A. Coatesworth, M. Beasley, T. Roques, C. Martin, P. Ryan, G. Gerrard, D. Power, C. Bremmer, T. Consortium, I. Tomlinson, L.G. Carvajal-Carmona, Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J. Med. Genet. 49(3), 158–163 (2012). https://doi.org/10.1136/jmedgenet-2011-100586 CrossRefPubMed A.M. Jones, K.M. Howarth, L. Martin, M. Gorman, R. Mihai, L. Moss, A. Auton, C. Lemon, H. Mehanna, H. Mohan, S.E. Clarke, J. Wadsley, E. Macias, A. Coatesworth, M. Beasley, T. Roques, C. Martin, P. Ryan, G. Gerrard, D. Power, C. Bremmer, T. Consortium, I. Tomlinson, L.G. Carvajal-Carmona, Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J. Med. Genet. 49(3), 158–163 (2012). https://​doi.​org/​10.​1136/​jmedgenet-2011-100586 CrossRefPubMed
12.
Zurück zum Zitat H. He, W. Li, S. Liyanarachchi, Y. Wang, L. Yu, L.K.Genutis, S. Maharry, J.E. Phay, R. Shen, P. Brock, A. de la Chapelle, The role of NRG1 in the predisposition to papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. (2017). https://doi.org/10.1210/jc.2017-01798 H. He, W. Li, S. Liyanarachchi, Y. Wang, L. Yu, L.K.Genutis, S. Maharry, J.E. Phay, R. Shen, P. Brock, A. de la Chapelle, The role of NRG1 in the predisposition to papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. (2017). https://​doi.​org/​10.​1210/​jc.​2017-01798
16.
Zurück zum Zitat L.E.B. de Mello, A.N. Araujo, C.X. Alves, F.J.P. de Paiva, J. Brandao-Neto, J.M. Cerutti, The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds. Clin. Endocrinol. 87(1), 113–114 (2017). https://doi.org/10.1111/cen.13352 CrossRef L.E.B. de Mello, A.N. Araujo, C.X. Alves, F.J.P. de Paiva, J. Brandao-Neto, J.M. Cerutti, The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds. Clin. Endocrinol. 87(1), 113–114 (2017). https://​doi.​org/​10.​1111/​cen.​13352 CrossRef
17.
Zurück zum Zitat C. Colombo, M. Muzza, M.C. Proverbio, G. Ercoli, M. Perrino, V. Cirello, L. Vicentini, S. Ferrero, L. Fugazzola, Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review. Clin. Endocrinol. 86(6), 837–844 (2017). https://doi.org/10.1111/cen.13316 CrossRef C. Colombo, M. Muzza, M.C. Proverbio, G. Ercoli, M. Perrino, V. Cirello, L. Vicentini, S. Ferrero, L. Fugazzola, Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review. Clin. Endocrinol. 86(6), 837–844 (2017). https://​doi.​org/​10.​1111/​cen.​13316 CrossRef
22.
Zurück zum Zitat R. Sahasrabudhe, J. Stultz, J. Williamson, P. Lott, A. Estrada, M. Bohorquez, C. Palles, G. Polanco-Echeverry, E. Jaeger, L. Martin, M. Magdalena Echeverry, I. Tomlinson, L.G. Carvajal-Carmona, Tcukin: The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer. J. Clin. Endocrinol. Metab. 10(3), 1098–1103 (2016). https://doi.org/10.1210/jc.2015-3928 CrossRefPubMed R. Sahasrabudhe, J. Stultz, J. Williamson, P. Lott, A. Estrada, M. Bohorquez, C. Palles, G. Polanco-Echeverry, E. Jaeger, L. Martin, M. Magdalena Echeverry, I. Tomlinson, L.G. Carvajal-Carmona, Tcukin: The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer. J. Clin. Endocrinol. Metab. 10(3), 1098–1103 (2016). https://​doi.​org/​10.​1210/​jc.​2015-3928 CrossRefPubMed
24.
Zurück zum Zitat X. Shen, G. Zhu, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A.K. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sykorova, M. Xing, Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J. Clin. Oncol. JCO2017745497 (2017). https://doi.org/10.1200/JCO.2017.74.5497 X. Shen, G. Zhu, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A.K. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sykorova, M. Xing, Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J. Clin. Oncol. JCO2017745497 (2017). https://​doi.​org/​10.​1200/​JCO.​2017.​74.​5497
31.
40.
Zurück zum Zitat G. Atzmon, M. Cho, R.M. Cawthon, T. Budagov, M. Katz, X. Yang, G. Siegel, A. Bergman, D.M. Huffman, C.B. Schechter, W.E. Wright, J.W. Shay, N. Barzilai, D.R. Govindaraju, Y. Suh, Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc. Natl Acad. Sci. USA 107(Suppl. 1), 1710–1717 (2010). https://doi.org/10.1073/pnas.0906191106 CrossRefPubMed G. Atzmon, M. Cho, R.M. Cawthon, T. Budagov, M. Katz, X. Yang, G. Siegel, A. Bergman, D.M. Huffman, C.B. Schechter, W.E. Wright, J.W. Shay, N. Barzilai, D.R. Govindaraju, Y. Suh, Evolution in health and medicine Sackler colloquium: Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc. Natl Acad. Sci. USA 107(Suppl. 1), 1710–1717 (2010). https://​doi.​org/​10.​1073/​pnas.​0906191106 CrossRefPubMed
41.
Zurück zum Zitat W. Pan, L. Zhou, M. Ge, B. Zhang, X. Yang, X. Xiong, G. Fu, J. Zhang, X. Nie, H. Li, X. Tang, J. Wei, M. Shao, J. Zheng, Q. Yuan, W. Tan, C. Wu, M. Yang, D. Lin, Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Hum. Mol. Genet. 25(9), 1875–1884 (2016). https://doi.org/10.1093/hmg/ddw056 CrossRefPubMed W. Pan, L. Zhou, M. Ge, B. Zhang, X. Yang, X. Xiong, G. Fu, J. Zhang, X. Nie, H. Li, X. Tang, J. Wei, M. Shao, J. Zheng, Q. Yuan, W. Tan, C. Wu, M. Yang, D. Lin, Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Hum. Mol. Genet. 25(9), 1875–1884 (2016). https://​doi.​org/​10.​1093/​hmg/​ddw056 CrossRefPubMed
Metadaten
Titel
Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease
verfasst von
Chen-Tian Shen
Guo-Qiang Zhang
Zhong-Ling Qiu
Hong-Jun Song
Zhen-Kui Sun
Quan-Yong Luo
Publikationsdatum
02.03.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01878-0

Weitere Artikel der Ausgabe 3/2019

Endocrine 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.